|
Reduced intensity conditioning and co-transplantation of unrelated peripheral stem cells combined with umbilical cord mesenchymal stem/stroma cells for young patients with refractory severe aplastic anemia.
|
Nov 2013
|
Int J Hematol
|
aplastic anemia
|
|
Specific Plasma Autoantibody Reactivity in Myelodysplastic Syndromes
|
Nov 2013
|
Sci Rep
|
myelodysplastic syndromes (MDS)
|
|
Transplantation for myelodysplastic syndromes 2013.
|
Nov 2013
|
Curr Opin Hematol
|
myelodysplastic syndromes (MDS)
|
|
Epigenetics of myelodysplastic syndromes
|
Nov 2013
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
|
Comparison of 24-month outcomes in chelated and non-chelated lower-risk patients with myelodysplastic syndromes in a prospective registry
|
Nov 2013
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
|
A prospective multicenter study of paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure.
|
Nov 2013
|
Cytometry B Clin Cytom
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Paroxysmal nocturnal hemoglobinuria and the age of therapeutic complement inhibition
|
Nov 2013
|
Expert Rev Clin Immunol
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
New therapeutic approaches for protecting hematopoietic stem cells in aplastic anemia.
|
Nov 2013
|
Immunol Res
|
aplastic anemia
|
|
Long-term outcome after immunosuppressive therapy with horse or rabbit antithymocyte globulin and cyclosporine for severe aplastic anemia in children.
|
Nov 2013
|
Haematologica
|
aplastic anemia
|
|
Expression of nucleoside metabolizing enzymes in myelodysplastic syndromes and modulation of response to azacitidine
|
Nov 2013
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
